ARNO THERAPEUTICS, INC

Profile

Company Names

ARNO THERAPEUTICS, INC

Addresses

200 ROUTE 31 NORTH, SUITE 104, FLEMINGTON, NJ 08822

4 CAMPUS DRIVE, SECOND FLOOR, PARSIPPANY, NJ 07054

Phone Numbers

862-703-7170
862-703-7175

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$54,867,260.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2016-08-15 
$4,510,182.00 
$4,510,182.00 
$0.00 
Equity 
3
2013-10-29 
$30,840,078.00 
$30,840,078.00 
$0.00 
Equity 
2
2012-11-26 
$11,130,000.00 
$18,425,000.00 
$7,295,000.00 
Equity, Debt 
1
2010-09-09 
$8,387,000.00 
$13,225,000.00 
$4,838,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ARIE 
S. 
BELLDEGRUN 
DIRECTOR
ARNO THERAPEUTICS, INC   |  KITE PHARMA, INC.   |  NILE THERAPEUTICS, INC.   |  BYHEART, INC.   |  ICONOVIR BIO, INC.
ARIE 
S. 
BELLDEGRUN, M.D. 
DIRECTOR
HANA BIOSCIENCES INC   |  ARNO THERAPEUTICS, INC   |  KRONOS BIO, INC.
ROBERT 
I. 
FALK 
DIRECTOR
ARNO THERAPEUTICS, INC
WILLIAM 
F. 
HAMILTON 
DIRECTOR
YAUPON THERAPEUTICS INC   |  ARNO THERAPEUTICS, INC
WILLIAM 
F. 
HAMILTON, PH.D. 
DIRECTOR
ARNO THERAPEUTICS, INC
TOMER 
 
KARIV 
DIRECTOR
ARNO THERAPEUTICS, INC   |  CHECK-CAP LTD   |  LOGICBIO THERAPEUTICS, INC.   |  VBI VACCINES INC/BC   |  IMEL BIOTHERAPEUTICS, INC.   |  ABCURO, INC.
PETER 
M. 
KASH 
DIRECTOR
NILE THERAPEUTICS, INC.   |  ARNO THERAPEUTICS, INC
JOSHUA 
A. 
KAZAM 
DIRECTOR
NILE THERAPEUTICS, INC.   |  ARNO THERAPEUTICS, INC   |  KITE PHARMA, INC.   |  KIRAX CORP   |  VETERINARY PRIME, INC.   |  ALLOGENE THERAPEUTICS, INC.   |  KRONOS BIO, INC.   |  ICONOVIR BIO, INC.   |  BYHEART, INC.
GLENN 
R. 
MATTES 
EXECUTIVE OFFICER, DIRECTOR
ARNO THERAPEUTICS, INC
JAY 
 
MOORIN 
DIRECTOR
GLOUCESTER PHARMACEUTICALS INC   |  PREDICTIVE BIOSCIENCES, INC   |  METHYLGENE INC.   |  MEVION MEDICAL SYSTEMS, INC.   |  PEGASI ENERGY RESOURCES CORPORATION.   |  ARNO THERAPEUTICS, INC   |  CORINO THERAPEUTICS, INC.
SCOTT 
L. 
NAVINS 
EXECUTIVE OFFICER
ARNO THERAPEUTICS, INC
STEFAN 
 
PRONIUK, PH.D. 
EXECUTIVE OFFICER
ARNO THERAPEUTICS, INC
YACOV 
 
REIZMAN 
DIRECTOR
ARNO THERAPEUTICS, INC
STEVEN 
B. 
RUCHEFSKY 
DIRECTOR
KITE PHARMA, INC.   |  ARNO THERAPEUTICS, INC
DAVID 
M. 
TANEN 
DIRECTOR, EXECUTIVE OFFICER
NILE THERAPEUTICS, INC.   |  ARNO THERAPEUTICS, INC   |  VETERINARY PRIME, INC.   |  ALLOGENE THERAPEUTICS, INC.   |  KRONOS BIO, INC.   |  NEOGENE THERAPEUTICS, INC.   |  ICONOVIR BIO, INC.
RANDY 
H. 
THURMAN 
DIRECTOR
IKARIA HOLDINGS INC   |  ARNO THERAPEUTICS, INC   |  OUTLOOK THERAPEUTICS, INC.
ALEXANDER 
 
ZUKIWSKI, M.D. 
EXECUTIVE OFFICER, DIRECTOR
ARNO THERAPEUTICS, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-08-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-08-15 
2013-11-13
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-10-29 
2012-12-06
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-11-26 
2012-12-05
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-11-26 
2010-09-23
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2010-09-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
MAXIM GROUP LLC
120708
MAXIM GROUP LLC
120708
RIVERBANK CAPITAL SECURITIES, INC.
135310
RIVERBANK CAPITAL SECURITIES, INC.
135310
I-BANKERS SECURITIES, INC.
41352
I-BANKERS SECURITIES, INC.
41352